Trademark: 97638731
Word
SANTHERA
Status Date
Wednesday, August 28, 2024
Filing Date
Wednesday, October 19, 2022
Published for Opposition
Tuesday, July 4, 2023
5 Pharmaceutical preparations for the treatment of ocular, inflammatory and pulmonary diseases, but not in the field of oncology and rheumatoid arthritis
The mark consists of the word "santhera" appearing in lower case lettering with two arched lines appearing alongside and to the left of the word.
Color is not claimed as a feature of the mark.
Oct 22, 2022
New Application Entered
Oct 27, 2022
Teas Voluntary Amendment Received
Oct 27, 2022
Teas Amendment Entered Before Attorney Assigned
Nov 3, 2022
New Application Office Supplied Data Entered
Nov 4, 2022
Notice Of Design Search Code E-Mailed
Mar 2, 2023
Assigned To Examiner
Mar 9, 2023
Non-Final Action Written
Mar 9, 2023
Non-Final Action E-Mailed
Mar 9, 2023
Notification Of Non-Final Action E-Mailed
May 24, 2023
Teas Response To Office Action Received
May 24, 2023
Correspondence Received In Law Office
May 24, 2023
Teas/Email Correspondence Entered
May 26, 2023
Approved For Pub - Principal Register
Jun 14, 2023
Notification Of Notice Of Publication E-Mailed
Jul 4, 2023
Published For Opposition
Jul 4, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 29, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 30, 2024
Teas Request To Divide Received
Jan 30, 2024
Divisional Request Received
Jan 30, 2024
Sou Extension 1 Filed
Jan 30, 2024
Sou Teas Extension Received
Feb 12, 2024
Case Assigned To Intent To Use Paralegal
Feb 15, 2024
Divisional Processing Complete
Feb 15, 2024
Sou Extension 1 Granted
Feb 16, 2024
Corrected Noa E-Mailed
Feb 16, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2024
Sou Teas Extension Received
Aug 28, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2024
Sou Extension 2 Filed
Aug 28, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24
